LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.

Biotechnology

Health Care

Health Diagnostics

LEX Diagnostics

Ed Farrell

Lucie Matejikova

Elliott Spain

Tim Schuller

Heather Danks (nee Murton)

Chris Hole

Andrew Anyakwo

Amaru Araya-Williams

The Research and Development team at LEX Diagnostics is responsible for innovating and optimizing molecular diagnostic technologies, with a particular focus on streamlining PCR processes for nasal and oral samples. This multidisciplinary team collaborates on assay development, reagent production, and overall product integration, ensuring that new diagnostic solutions are both cost-effective and efficient for detecting viral pathogens in primary care settings. Their expertise drives the advancement of LEX's cutting-edge medical devices, enhancing diagnostic accuracy and accessibility.

Research and Development

Engineering and Manufacturing

Leadership Team

Research and Development

About

Team members

Other teams at LEX Diagnostics

Engineering and Manufacturing

Leadership Team